CHMP positive for seladelpar for the treatment of primary biliary cholangitis in combination with ursodeoxycholic acid – Gilead Sciences
Gilead Sciences, Inc. announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending seladelpar for the… read more.